03/24/2026
🚨 Breakthrough for the SLC6A1 community 🚨
A newly published study has identified something we’ve all been searching for:
👉 a quantifiable, objective biomarker for SLC6A1-related neurodevelopmental disorder.
Researchers analyzed EEG data and found that delta power (slow brain wave activity) is significantly elevated in individuals with SLC6A1—and, importantly, it behaves differently over time than in typically developing children. ()
Even more exciting:
✨ This signal can distinguish patients from controls with very high accuracy (AUC ~0.93)
✨ It is measurable using scalable, real-world EEG tools
✨ It shows a unique developmental trajectory, increasing with age instead of decreasing
Introduction: SLC6A1-related neurodevelopmental disorder (SLC6A1-NDD) is an epileptic encephalopathy linked to mutations in the SLC6A1 gene and is characterized by early-onset seizures and developmental delays. Despite the growing recognition of SLC6A1 as a major cause of early-onset epilepsy, the e...